RT Journal Article
SR Electronic
T1 A passive “OneHealth” surveillance system to track canine rabies in urban India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.23.22271029
DO 10.1101/2022.02.23.22271029
A1 Vanak, Abi. Tamim
A1 Panchamia, Neha
A1 Banerji, Indrakshi
A1 Nair, Malvika
YR 2022
UL http://medrxiv.org/content/early/2022/02/25/2022.02.23.22271029.abstract
AB Robust and widely implementable “OneHealth” surveillance systems are required to detect and control the spread of zoonotic infectious diseases. Using technological tools coupled with a rapid field response and rapid diagnostics can help in surveillance of deadly diseases such as rabies, even in densely populated urban areas. Here, we describe the use of an animal rescue system (Hawk Data Pro) that was adapted as a passive surveillance tool for rabies in a large metropolis in India. We used a webline and helpline that reported injured or sick animals to an animal rescue facility to determine possible rabies cases in street animals in Pune city in western India. Suspected rabid animals were tested using lateral flow assays and this information was used to direct awareness materials on rabies as well as in conducting mass dog vaccinations in areas that reported multiple cases. Over a ∼4 year period, we received over 90,700 calls or reports, of which 1162 calls were for suspected rabies cases in dogs, and 6 for other animals (cats, goats and cattle). Of these, 749 dogs and 4 other animals tested positive for rabies. Most of the cases were reported from the densely human populated central Pune region. In response, ∼21,000 people were provided with educational materials on post-bite management, and ∼23,000 dogs were vaccinated. We show that the adoption of the Hawk Data Pro system as a passive surveillance tool allowed us to document an ongoing outbreak of rabies in a large metropolis in India. Such systems can be modified or adapted to other areas as well to meet the surveillance and reporting requirements of the WHO’s Zeroby30 strategy to eliminate rabies globally.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded through a DBT/Wellcome Trust India Alliance grant to ATV (Grant number: IA/CPHI/15/1/502028).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors